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Abstract
Progressive and relatively circumscribed loss of semantic knowledge, referred to as semantic dementia (SD) which
falls under the broader umbrella of frontotemporal dementia, was officially identified as a clinical syndrome less
than 50 years ago. Here, we review recent neuroimaging, pathological, and genetic research in SD. From a
neuroimaging perspective, SD is characterised by hallmark asymmetrical atrophy of the anterior temporal pole
and anterior fusiform gyrus, which is usually left lateralised. Functional magnetic resonance imaging (fMRI) studies
have revealed widespread changes in connectivity, implicating the anterior temporal regions in semantic deficits
in SD. Task-related fMRI have also demonstrated the relative preservation of frontal and parietal regions alongside
preserved memory performance. In addition, recent longitudinal studies have demonstrated that, with disease
progression, atrophy encroaches into the contralateral temporal pole and medial prefrontal cortices, which reflects
emerging changes in behaviour and social cognition. Notably, unlike other frontotemporal dementia subtypes, recent
research has demonstrated strong clinicopathological concordance in SD, with TDP43 type C as the most common
pathological subtype. Moreover, an underlying genetic cause appears to be relatively rare in SD, with the majority of
cases having a sporadic form of the disease. The relatively clear diagnosis, clinical course, and pathological homogeneity
of SD make this syndrome a promising target for novel disease-modifying interventions. The development of
neuroimaging markers of disease progression at the individual level is an important area of research for future
studies to address, in order to assist with this endeavour.
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Background
Semantic dementia (SD), a progressive neurodegenerative
disorder affecting language, was empirically described only
relatively recently. In the early 1970s, the conceptualisa-
tion of memory into two distinct systems, an episodic
system and a semantic system by Tulving [1], coincided
with the report by Warrington [2] of three individuals
who presented with visual object agnosia, a profound in-
ability to recognise or identify objects. In light of this new
memory system and additional assessment, Warrington
recognised that the constellation of symptoms of these
patients could be conceptualised as an underlying loss of
semantic memory. Since this seminal paper, the syndrome,
which is characterised by circumscribed but profound loss
of semantic knowledge, has been referred to as SD [3, 4]
and, more recently, as semantic-variant primary progres-
sive aphasia (PPA) [5]. Less than 50 years later, our under-
standing of this striking clinical syndrome has advanced.
In this review, we will consider how recent studies in
imaging, genetics, and pathology over the last decade have
informed our knowledge of SD.
Contemporary consensus criteria for SD require indi-
viduals to first meet criteria for PPA; i.e. the most
prominent clinical symptom to be in the domain of
language, and evidence of subsequent impaired activities
of daily living. Then, sub-classification as semantic-
variant is based on impaired confrontation naming and
single-word comprehension, with supportive features
including impaired object knowledge, surface dyslexia or
dysgraphia, spared repetition, and spared speech produc-
tion. In a series of 100 cases all of whom underwent
longitudinal follow-up, the mean age at presentation was
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64.2 years but with a range of 40–79 years [6]. There
was a 50% survival of 12.8 years indicating a slower pro-
gression than in other forms of frontotemporal dementia
[6]. Studies of the prevalence and incidence of SD have
been relatively limited; however, a recent epidemiology
study estimated the prevalence of frontotemporal de-
mentia at 10.8/100,000, with SD accounting for approxi-
mately one-third of these cases [7] in line with previous
estimates [8]. Whether this prevalence is similar across
countries, however, remains to be examined, as most
existing epidemiological data hail from European studies.
Clinical presentation and cognitive profile
Clinically, patients with SD show a speech profile that is
relatively fluent but empty of content, producing a pattern
of so-called logorrhoea. Importantly, loss of semantic
knowledge is observed irrespective of testing modality [9].
Impaired word comprehension is a mandatory feature and
patients demonstrate word alienation in that they are able
to repeat words such as “violin” or “caterpillar” but have
no idea of their meaning. This deficit gradually progresses
from low frequency and less familiar words, such as those
mentioned, to more common words. Adlam et al. [10]
demonstrated that SD patients are also impaired on non-
verbal semantic matching tasks, tests of colour knowledge,
sound knowledge, and object-use knowledge, which do
not require naming or verbal comprehension even from
an early stage of the disease. Such findings have provided
evidence that, in SD, symptomatology reflects a profound
and progressive loss of conceptual knowledge which is not
limited to performance on verbal tasks [11]. There is also
accompanying surface dyslexia: patients are unable to cor-
rectly pronounce irregular words such as pint which they
read to rhyme with hint or flint.
In contrast, recent studies have confirmed that epi-
sodic memory is relatively preserved in SD, particularly
when tasks with minimal conceptual loading are em-
ployed [12, 13]. The intact performance on traditional
non-conceptually loaded episodic memory tasks con-
verges with the performance of SD patients on autobio-
graphical memory tasks. Patients typically show relatively
preserved recollection of recent autobiographical memory
in the context of poorer remote autobiographical memory
(known as the reverse temporal gradient or step-function),
reflecting increased semanticisation of past events (e.g.
[14–16]). This is in stark contrast to the compromised
ability of SD patients to project forwards in time to im-
agine possible future events (e.g. [17]). These deficits in
future-oriented thought are attributable to semantic pro-
cessing impairments, and have led to the advancement of
the semantic scaffolding hypothesis which proposes that
semantic knowledge is required to impart structure and
meaning during the process of future simulation [18].
Changes in behaviour and social cognition are increas-
ingly recognised in SD [19]. Clinically, SD patients often
show mental rigidity and inflexible behaviour. For example,
patients may become obsessive in tasks they engage in (e.g.
we have noticed patients spending hours completing jig-
saw puzzles), food preferences (usually restricted to spe-
cific foods), or daily routines (e.g. clockwatching). In
addition, SD patients may have increased apathy and
changes in eating behaviour, as well as loss of empathy,
impaired emotion perception and emotional memories,
and reduced theory of mind capacity [20–24]. Over time,
many patients become essentially mute with only a lim-
ited repertoire of stereotypic phrases and a complete
loss of word comprehension. Changes in emotional
capacity as well as increased rigid behaviours are asso-
ciated with higher carer burden (e.g. [25]), and progres-
sive behavioural changes and/or increasing disability
leads to residential care in most cases [6] (Table 1).
Imaging
Structural imaging
An extensive body of brain imaging studies have investi-
gated structural and functional brain abnormalities in
patients with SD. At presentation, visual inspection of
magnetic resonance imaging (MRI) typically reveals hall-
mark bilateral, but asymmetric atrophy of the anterior
temporal lobes, which is usually left lateralised (Fig. 1).
With the development of neuroimaging techniques to
statistically measure this degeneration, whole-brain
structural MRI studies using voxel-based morphometry
(VBM) have confirmed grey matter loss, which is rela-
tively localised to the temporal lobe (left-predominant),
with some involvement of frontal and limbic regions
(e.g. [26]). Specifically, these regions include asymmetric
but bilateral involvement of the temporal pole, the fusi-
form gyrus, middle and inferior temporal gyrus, ventro-
medial prefrontal cortex, amygdala, hippocampus, and
the insula, which have been confirmed by a recent meta-
analysis [27]. Importantly, the asymmetric hippocampal
involvement is also considered one of the hallmark fea-
tures of SD. In addition, surface-based imaging studies
Table 1 Cognitive profile of semantic dementia at presentation
Impaired Relatively preserved
Confrontation naming Episodic memory
Word comprehension Navigation




Future thinking Processing speed
Emotion perception and empathy Phonology and syntax
Theory of mind Non-verbal problem solving
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have demonstrated predominantly left anterior temporal
cortical thinning on both the lateral and ventral surfaces
of the temporal lobe (e.g. [28, 29]). Debate continues
concerning the most critical region, but it appears that
bilateral atrophy of the anterior fusiform region is
required to generate the syndrome of SD.
More recently, white matter changes in SD have also
been mapped using diffusion tensor imaging (DTI) and
tractrography analyses. These studies have demonstrated
that patients with SD also have reduced white matter
integrity in the left temporal lobe, periventricular white
matter, corpus callosum, and in white matter tract areas
of the fornix, inferior longitudinal fasciculus, and the un-
cinate fasciculus [30]. Studies using DTI have also
shown reduced structural connectivity in frontotemporal
pathways in SD, particularly in the uncinate, arcuate,
and inferior longitudinal fasciculi [31, 32]. Although a
range of DTI metrics have been applied across studies,
the areas of abnormality show spatial overlap and are
mostly adjacent to regions showing grey matter atrophy
[33, 34]. Recently, a tractrography study has uncovered
the role of the frontal aslant tract in verbal fluency whilst
degeneration of the uncinate fasciculus is uniquely corre-
lated with semantic deficits [35].
Despite the hallmark pattern of atrophy at presenta-
tion in this syndrome, how atrophy progresses over time
has been relatively poorly understood, in part due to the
methodological difficulties in acquiring and analysing
longitudinal neuroimaging data. In recent years, how-
ever, rapid progress has been made in this area, with an
emergence of longitudinal neuroimaging studies tracking
progression. These studies have revealed that, in SD,
atrophy extends from the anterior temporal lobe into
the posterior temporal and/or the inferior frontal lobes
with disease progression [36]. Some studies have sug-
gested left greater than right hemisphere atrophy with
disease progression [37]. A recent longitudinal imaging
study in a larger cohort, however, demonstrated pro-
gressive right hemisphere cortical atrophy in SD, despite
patients showing left-dominant atrophy at presentation
[38]. Longitudinal studies of white matter changes have
also revealed involvement of the right hemisphere with
disease progression, with focal left lateralized degeneration
involving the uncinate and anterior inferior longitudinal
fasciculi at baseline, which spreads to the right hemi-
sphere with disease progression [39, 40]. In summary,
although the cortical atrophy is relatively localised in
the left hemisphere early in the disease, progressive
grey and white matter involvement of the frontal and
contralateral temporal lobe is observed as the disease
progresses (Fig. 2).
Molecular imaging
In addition to MRI, 2-(Fluorine-18)fluoro-2-deoxy-D-
glucose (18F-FDG) positron emission tomography
(PET) (FDG-PET) [41] has been used to visualize cere-
bral glucose metabolism, a measure which increases
with regional synaptic activity and decreases with
synaptic dysfunction or neural degeneration. As such,
Fig. 1 Axial MRI scans showing typical anterior and middle temporal structural abnormalities in early left and right lateralised SD. L left, R right,
SD semantic dementia
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FDG-PET is a functional imaging marker useful for
early diagnosis of dementia, although evidence regarding
its utility for differential diagnosis in PPA syndromes
is limited [42]. In SD, unsurprisingly, left dominant
cerebral glucose metabolism is reduced in the tem-
poral lobes [3], especially the left temporal pole [43]
and the hippocampus [36]. These metabolic reduc-
tions correspond to observed regional grey matter
atrophy patterns [44]. Longitudinal FDG-PET studies
have also reported right lateralised reduction in glu-
cose metabolism in the temporal lobes with disease
progression, which is associated with impaired cogni-
tive performance [45].
Functional imaging
Recent studies have also begun to investigate functional
brain changes in SD. Functional MRI (fMRI) measures
brain activity by detecting changes associated with the
blood flow and the blood oxygen level-dependent
(BOLD) response. fMRI can be performed either at rest
(i.e. resting-state fMRI) or during performance of spe-
cific tasks to examine baseline brain activity or activa-
tion concomitant with cognitive performance [46].
Whole-brain and regional functional connectivity can
be further derived from resting-state fMRI by measuring
the correlation of the time series of BOLD signals across
brain regions [47, 48]. Resting-state fMRI studies in SD
have generally found reduced functional connectivity in
the executive [30] and language [32] networks. Seed-based
analyses in SD have described extensive disruptions in
functional connectivity between the anterior temporal
lobe and a broad range of brain regions across the tem-
poral, frontal, parietal, and occipital lobes [49]. Independ-
ent component analysis has indicated that SD is also
associated with changes in functional connectivity in the
prefrontal cortex bilaterally, the anterior cingulate, and in
different components within the default mode, salience,
and emotion networks [50]. In summary, these results
show that SD patients manifest extensive functional con-
nectivity alterations beyond the core atrophic regions in
the anterior temporal lobes and related language net-
works. It should be noted that while these studies have re-
vealed extensive changes in functional connectivity
associated with SD, most have not examined how these
changes relate to hallmark cognitive and behavioural
symptoms in these patients. As such, future studies ad-
dressing the behavioural relevance of the observed brain
connectivity changes are warranted.
Imaging studies have recently begun to establish the
neural correlates of the clinical and cognitive changes
associated with SD. In SD, bilateral (yet asymmetrical
left > right) neurodegeneration of the anterior temporal
Fig. 2 Brain imaging findings in SD at presentation and with disease progression. a Cross-sectional multimodal imaging findings in 10 SD patients versus
21 healthy controls: reduced regional grey matter density (top row), reduced FDG-PET (second row), increased radial diffusivity (third row), and composite of
multimodal findings (fourth row). From Acosta-Carbonero et al. [31] with permission. b Baseline and longitudinal changes in cortical thickness in 22 left
SD vs 9 right SD patients. From Kumfor et al. [14, 38] with permission. c Longitudinal white matter changes from baseline in 11 SD patients. From Lam
et al. [40] with permission. FA fractional anisotropy, FDG-PET fluorodeoxyglucose positron emission tomography, FDR, L left, MD mean diffusivity, R right,
RadialD radial diffusivity, SD semantic dementia, TBSS tract-based spatial statistics, VBM voxel-based morphometry, FDR false discovery rate
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lobes is associated with profound semantic deficits, yet
syntax, phonology, and fluency are strikingly spared. A
set of recent fMRI studies sought to differentiate compo-
nents of language processing in SD. These studies have
described both task-positive and task-negative changes
in the language network in SD patients compared to
controls showing: i) decreased activation in the fusiform
and superior temporal gyrus [51, 52]; ii) increased acti-
vation in the intraparietal sulcus [51], the inferior frontal
gyrus [52], and the left superior temporal gyrus [53]; and
iii) failure of deactivation in the anterior temporal lobe
[54]. These results further emphasise the suggested role
of the anterior temporal lobes in the combination of
both low-level perceptual processing and higher-level in-
tegration of semantic processing. Taken together, these
findings suggest that spared syntactic processing in SD
depends on preserved functionality of left frontal, par-
ietal and, to lesser degree, posterior temporal regions.
The relative integrity of regions beyond the medial tem-
poral cortices, such as the posterior cingulate and frontal
cortices, also seems to sub-serve other cognitive functions
such as the preserved episodic memory performance in
SD patients [13, 55].
Right lateralised semantic dementia
A proportion of patients present with right greater than
left lateralised atrophy, referred to as right SD, or right
temporal variant frontotemporal dementia [56]. These pa-
tients often present with profound behavioural changes,
which can make distinction from the behavioural variant
of frontotemporal dementia challenging [57]. Importantly,
increasing evidence has revealed that the extent of be-
havioural and social cognition changes is related to
integrity of the right temporal pole in this syndrome
[21, 38]. Patients with right lateralised atrophy also
tend to show greater social cognition deficits than
patients with left lateralised SD, while a subset present
with prosopagnosia as the primary clinical feature [20, 38].
Improved diagnosis of right SD, together with better un-
derstanding of features which give rise to the manifest-
ation of this syndrome, will be important for future
studies to address.
Pathology
Volumetric analyses in autopsy tissue have shown that,
in addition to the frontal and anterior temporal cortices,
significant degeneration in the cingulate cortices, anterior
thalamus, and hippocampal head is apparent by the end of
the disease course [58]. The regions within the limbic
memory circuit (also known as the Papez circuit) that re-
main intact include the mammillary bodies, hippocampal
body and tail, and memory relays between these key re-
gions, a finding that almost certainly accounts for the rela-
tive preservation of episodic memory in patients with SD
[15, 58]. Interestingly, a selective loss of von Economo
neurons has been identified in the anterior cingulate
cortices in SD [58, 59] and may account for some of
the behavioural deficits that emerge with disease pro-
gression [19].
At a microscopic level, the main class of pathology
identified in patients with SD is frontotemporal lobar
degeneration with TAR DNA-binding protein 43
(FTLD-TDP) [6, 60, 61]. Based on the morphology and
cortical distribution of the TDP43 lesions, four classes
of FTLD-TDP (subtypes A–D) are recognised [62, 63].
In contrast to TDP subtypes A, B, and D, where TDP-
43 manifests as neuronal cytoplasmic inclusions with
and without short dystrophic neurites and/or intranuc-
lear inclusions, TDP type C is characterised by long
dystrophic neurites [62, 63] (see Fig. 3). Notably, clini-
copathological studies have consistently found TDP
type C to account for the majority of patients with SD.
Fig. 3 llustration of the FTLD-TDP subtypes. From Tan et al. [63] with permission
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Neuroimaging analyses of TDP subtypes have found
TDP type C to be associated with asymmetric anterior
temporal lobe atrophy, but this likely reflects the high
representation of SD in patients with this pathological
subtype [64]. Prominent left anterior temporal thinning
is also seen in patients with SD who have FTLD-
ubiquitin pathology at autopsy [65].
Nevertheless, FTLD-TDP types A and B, Tau-positive
frontotemporal lobar degeneration (FTLD-tau) and
Alzheimer’s disease (AD) have been reported in 17% to
32% of patients with SD [6, 64, 66, 67]. Based on the
morphology and distribution of the predominant spe-
cies of tau deposited, FTLD-tau cases are subclassified
into 3R (i.e. Pick’s disease) and 4R tauopathies (i.e. cor-
ticobasal degeneration, progressive supranuclear palsy
and, more recently, globular glial tauopathy) [68, 69].
Almost all patients with SD and underlying FTLD-tau
pathology demonstrate the 3R tauopathy Pick’s disease
[6, 61, 67], with only one recent report of a patient in
which the 4R globular glial tauopathy was identified [70].
Finally, recent research efforts have attempted to iden-
tify FTLD pathological subtypes via cerebrospinal fluid
(CSF) biomarkers. Increased neurofilament light chain
(NfL) levels in the CSF are associated with neuronal and
axonal degeneration, and have been reported in patients
with neurodegenerative diseases, particularly in patients
with probable TDP43 pathology [71–74]. Specifically,
increased NfL levels in the CSF have been reported in
patients with SD [71, 72]. Although preliminary, these
studies indicate that increased NfL levels in the CSF
may represent a promising marker of underlying TDP
pathology. In summary, emerging clinicopathological re-
search demonstrates that, in the vast majority of cases,
TDP43 type C is the most common pathological sub-
type, rendering SD one of the most pathologically
homogenous frontotemporal syndromes.
Genetics
Unlike other forms of frontotemporal dementia,
SD is typically sporadic, and a suggestive family
history is identified in around 5% of patients only
[6, 75]. In the patients that do have a highly posi-
tive family history of dementia, mutation in the pro-
granulin (GRN) or expansion of the chromosome 9
open reading frame 72 (C9ORF72) gene have been de-
scribed [76, 77]. Notably, however, these mutations are
very rarely found in sporadic SD [78] and the C9ORF72
expansion has only been described in two patients,
both of whom demonstrated co-existing behavioural
changes [79, 80].
Interestingly, although a diagnosis of SD in association
with a frontotemporal dementia genetic abnormality is
rare, semantic impairment appears to develop quite
commonly in individuals carrying a mutation in the
GRN or microtubule associated protein tau (MAPT)
genes [75, 81]. Given that SD is consistently associated
with FTLD-TDP type C pathology, the rarity of muta-
tions identified in this syndrome is consistent with other
recognized geno-pathological associations within the
frontotemporal dementia spectrum (e.g. GRN with
FTLD-TDP subtype A; C9ORF72 with FTLD-TDP sub-
type B; and MAPT with FTLD-tau) [62]. With this in
mind, in individuals clinically presenting with SD and
with an absence of a strong family history, clinicians can
be confident that an underlying genetic abnormality is
unlikely.
Conclusions
As this review reveals, despite a relatively short history
much knowledge has been gained about the SD syndrome,
particularly over the last decade. Indeed, SD appears to be
one of the more straightforward frontotemporal dementia
subtypes. It has a clear clinical course, which begins with
language features and, with progression, affects behaviour
and social cognition; this reflects early and relatively cir-
cumscribed neurodegeneration of the anterior temporal
pole, which encroaches into medial prefrontal and pos-
terior temporal regions as well as into the contralateral
hemisphere with disease progression. Pathologically, it
is most commonly associated with TDP43 type C and
genetic causes are rare.
In spite of this progress, a number of outstanding ques-
tions remain which we hope research over the next decade
will address. Clinical phenotype is clearly influenced by
the laterality of pathology and associated atrophy in this
syndrome, with left lateralised atrophy initially manifesting
as loss of semantic knowledge (i.e. anomia) and right later-
alised atrophy initially manifesting as loss of person know-
ledge (i.e. prosopagnosia, knowledge of social norms),
giving important insights into the representation of con-
ceptual knowledge across hemispheres [36, 82]. Currently,
it remains unclear why only a subset of cases (~30% [56])
present with right lateralised atrophy, with the majority of
patients presenting with left lateralised neurodegeneration.
Future studies that consider pre-clinical variables (e.g.
handedness, occupational history, learning disabilities)
with the potential to influence vulnerability of brain hemi-
spheres to disease, may shed light on this issue (e.g. [83]).
Indeed, it has been suggested that patients with PPA have
a higher rate of pre-existing language disorders than
would be expected in the general population, but this has
not been investigated specifically in the SD clinical pheno-
type [83]. In addition, from a management perspective,
changes in behaviour, capacity to engage in social situa-
tions, and reduced empathy lead to increased burden
and stress in carers, which is often greater than in
carers of patients with the behavioural variant of fron-
totemporal dementia [14]. This may reflect inadequate
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psychoeducation of carers regarding the manifestation of
behavioural change in SD patients which is important for
clinicians to consider when interacting with family mem-
bers and carers of SD patients.
Clinically, one of the key issues on the horizon is the
development of drugs that target the deposition or clear-
ance of pathology. As these are likely to be specific to
pathological subtypes, SD appears to be a promising syn-
drome for drug developers to target, given the striking
clinicopathological concordance. Development of such
agents, however, has been hindered by the lack of
suitable animal models showing pathological changes
that mirror those seen in SD. Knowledge is also lack-
ing about the basic biological processes that underlie
the deposition of TDP43 type C in SD. Recent ad-
vances in CSF studies may represent a promising av-
enue to identify FTLD pathological subtypes in vivo.
The development of biomarkers such as these (e.g.
CSF NfL, neuroimaging, blood biomarkers) are essen-
tial for discrimination, prognosis, and prediction of
disease progression in SD. Improved understanding
of the pathophysiological mechanisms which give rise
to SD will also be essential for the development of
novel drug interventions. From an imaging perspec-
tive, new techniques to measure change in brain in-
tegrity and function with disease progression have
already started to make some headway. Applications
of these techniques at the individual level are likely
to be key to track disease progression and potentially
measure the efficacy of interventions as these become
available.
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